The U.S. Food and Drug Administration granted accelerated approval on November 5, 2026, to Johnson & …

The U.S. Food and Drug Administration (FDA) has approved Ilumya (tildrakizumab-asmn) for adults with active p…

Novartis's experimental cardiovascular drug pelacarsen failed to demonstrate a reduction in major cardiovasc…

XML A federal judge blocked a Trump administration rule on October 29, 2026, that would have required cer…

Eli Lilly's experimental diabetes drug retatrutide produced greater average reductions in blood sugar and bod…

Merck's experimental cancer medicine sacituzumab tirumotecan extended median overall survival to 19 m…

A major Ebola vaccine trial has begun in the Democratic Republic of the Congo (DRC), where researchers are invest…

More than half of young children identified as living with someone who has an active hepatitis B infection had a …

Bristol Myers Squibb disclosed on October 23, 2026, that a patient died during an early-stage clinical study of i…